Resonance Health Ltd

AU:RHT Australia Health Information Services
Market Cap
$11.52 Million
AU$18.61 Million AUD
Market Cap Rank
#30236 Global
#864 in Australia
Share Price
AU$0.04
Change (1 day)
+0.00%
52-Week Range
AU$0.03 - AU$0.06
All Time High
AU$0.28
Categories
Companies in Australia Health Information Services Technology
About

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron conce… Read more

Resonance Health Ltd (RHT) - Net Assets

Latest net assets as of December 2025: AU$10.94 Million AUD

Based on the latest financial reports, Resonance Health Ltd (RHT) has net assets worth AU$10.94 Million AUD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$17.96 Million) and total liabilities (AU$7.02 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$10.94 Million
% of Total Assets 60.9%
Annual Growth Rate 1.81%
5-Year Change -20.6%
10-Year Change 132.8%
Growth Volatility 118.24

Resonance Health Ltd - Net Assets Trend (1989–2025)

This chart illustrates how Resonance Health Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Resonance Health Ltd (1989–2025)

The table below shows the annual net assets of Resonance Health Ltd from 1989 to 2025.

Year Net Assets Change
2025-06-30 AU$9.39 Million -14.10%
2024-06-30 AU$10.93 Million +10.03%
2023-06-30 AU$9.94 Million -7.07%
2022-06-30 AU$10.69 Million -9.61%
2021-06-30 AU$11.83 Million +19.40%
2020-06-30 AU$9.91 Million +68.08%
2019-06-30 AU$5.89 Million +42.56%
2018-06-30 AU$4.13 Million +10.70%
2017-06-30 AU$3.73 Million -7.42%
2016-06-30 AU$4.03 Million -8.43%
2015-06-30 AU$4.41 Million +31.95%
2014-06-30 AU$3.34 Million +48.98%
2013-06-30 AU$2.24 Million -12.67%
2012-06-30 AU$2.57 Million -11.38%
2011-06-30 AU$2.90 Million -9.75%
2010-06-30 AU$3.21 Million -2.84%
2009-06-30 AU$3.30 Million +23.44%
2008-06-30 AU$2.68 Million -1.69%
2007-06-30 AU$2.72 Million +433.19%
2006-06-30 AU$510.36K -96.38%
2005-06-30 AU$14.11 Million +391.68%
2004-06-30 AU$2.87 Million +315.23%
2003-06-30 AU$690.97K +109.68%
2002-06-30 AU$-7.14 Million -174.31%
2000-06-30 AU$9.61 Million +30.21%
1999-06-30 AU$7.38 Million -64.14%
1998-06-30 AU$20.58 Million +47.79%
1997-06-30 AU$13.92 Million +17.39%
1996-06-30 AU$11.86 Million +136.03%
1995-06-30 AU$5.03 Million -2.94%
1994-06-30 AU$5.18 Million +1.57%
1993-06-30 AU$5.10 Million -3.14%
1992-06-30 AU$5.26 Million -3.41%
1991-06-30 AU$5.45 Million -4.54%
1990-06-30 AU$5.71 Million +15.81%
1989-06-30 AU$4.93 Million --

Equity Component Analysis

This analysis shows how different components contribute to Resonance Health Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 6723333800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$74.45 Million 792.83%
Other Comprehensive Income AU$2.54 Million 27.08%
Other Components AU$1.00 0.00%
Total Equity AU$9.39 Million 100.00%

Resonance Health Ltd Competitors by Market Cap

The table below lists competitors of Resonance Health Ltd ranked by their market capitalization.

Company Market Cap
PT Bank CIMB Niaga Tbk
MU:NKX
 		$6.64 Million
hGears AG
XETRA:HGEA
 		$6.64 Million
Talon Metals Corp
PINK:TLOFF
 		$6.64 Million
Hanwha Techwin Co. Ltd.
KQ:012450
 		$6.65 Million
Humbl Inc
OTCQB:HMBL
 		$6.64 Million
Xylo Technologies Ltd.
NASDAQ:XYLO
 		$6.64 Million
NGX Limited
PINK:NGXLF
 		$6.63 Million
South Star Mining Corp
V:STS
 		$6.63 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Resonance Health Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 10,931,634 to 9,390,797, a change of -1,540,837 (-14.1%).
  • Net loss of 1,732,939 reduced equity.
  • Other comprehensive income decreased equity by 93,651.
  • Other factors increased equity by 285,753.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-1.73 Million -18.45%
Other Comprehensive Income AU$-93.65K -1.0%
Other Changes AU$285.75K +3.04%
Total Change AU$- -14.10%

Book Value vs Market Value Analysis

This analysis compares Resonance Health Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.89x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 3.34x to 1.89x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1989-06-30 AU$0.01 AU$0.04 x
1990-06-30 AU$0.01 AU$0.04 x
1991-06-30 AU$0.01 AU$0.04 x
1992-06-30 AU$0.02 AU$0.04 x
1993-06-30 AU$0.02 AU$0.04 x
1994-06-30 AU$0.02 AU$0.04 x
1995-06-30 AU$0.02 AU$0.04 x
1996-06-30 AU$0.06 AU$0.04 x
1997-06-30 AU$7.26 AU$0.04 x
1998-06-30 AU$6.58 AU$0.04 x
1999-06-30 AU$1.75 AU$0.04 x
2000-06-30 AU$1.67 AU$0.04 x
2002-06-30 AU$-1.45 AU$0.04 x
2003-06-30 AU$0.01 AU$0.04 x
2004-06-30 AU$0.06 AU$0.04 x
2005-06-30 AU$0.13 AU$0.04 x
2006-06-30 AU$0.00 AU$0.04 x
2007-06-30 AU$0.01 AU$0.04 x
2008-06-30 AU$0.01 AU$0.04 x
2009-06-30 AU$0.01 AU$0.04 x
2010-06-30 AU$0.01 AU$0.04 x
2011-06-30 AU$0.01 AU$0.04 x
2012-06-30 AU$0.01 AU$0.04 x
2013-06-30 AU$0.01 AU$0.04 x
2014-06-30 AU$0.01 AU$0.04 x
2015-06-30 AU$0.01 AU$0.04 x
2016-06-30 AU$0.01 AU$0.04 x
2017-06-30 AU$0.01 AU$0.04 x
2018-06-30 AU$0.01 AU$0.04 x
2019-06-30 AU$0.01 AU$0.04 x
2020-06-30 AU$0.02 AU$0.04 x
2021-06-30 AU$0.03 AU$0.04 x
2022-06-30 AU$0.02 AU$0.04 x
2023-06-30 AU$0.02 AU$0.04 x
2024-06-30 AU$0.02 AU$0.04 x
2025-06-30 AU$0.02 AU$0.04 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Resonance Health Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -18.45%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -15.65%
  • • Asset Turnover: 0.62x
  • • Equity Multiplier: 1.91x
  • Recent ROE (-18.45%) is above the historical average (-82.36%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1997 -18.23% 0.00% 0.00x 2.06x AU$-3.93 Million
1998 0.37% 0.00% 0.00x 2.00x AU$-1.78 Million
1999 0.85% 0.00% 0.00x 1.67x AU$-492.17K
2000 5.41% 5.57% 0.33x 2.94x AU$-358.82K
2002 0.00% -152.38% 1.51x 0.00x AU$-1.75 Million
2003 883.25% 32119.36% 0.03x 1.04x AU$6.03 Million
2004 24.67% 22941.94% 0.00x 1.02x AU$450.22K
2005 7.87% 913.07% 0.01x 1.03x AU$-300.68K
2006 -3147.02% -5081.47% 0.34x 1.84x AU$-16.11 Million
2007 -26.64% -38.79% 0.59x 1.16x AU$-997.11K
2008 -1.55% -2.40% 0.59x 1.09x AU$-308.90K
2009 18.69% 27.32% 0.61x 1.12x AU$286.83K
2010 -3.18% -5.55% 0.49x 1.16x AU$-422.85K
2011 -10.95% -18.16% 0.50x 1.20x AU$-606.56K
2012 -10.48% -17.22% 0.47x 1.31x AU$-525.60K
2013 -9.10% -13.36% 0.50x 1.37x AU$-428.10K
2014 -2.17% -3.17% 0.53x 1.28x AU$-406.27K
2015 10.52% 18.96% 0.47x 1.18x AU$22.71K
2016 -9.52% -15.07% 0.52x 1.22x AU$-787.39K
2017 -8.14% -12.23% 0.54x 1.24x AU$-677.47K
2018 5.43% 7.76% 0.62x 1.13x AU$-188.80K
2019 21.55% 35.03% 0.56x 1.09x AU$680.64K
2020 -7.22% -19.49% 0.35x 1.06x AU$-1.71 Million
2021 4.95% 15.50% 0.30x 1.05x AU$-596.88K
2022 -10.68% -29.83% 0.33x 1.09x AU$-2.21 Million
2023 -7.85% -17.71% 0.40x 1.11x AU$-1.77 Million
2024 1.55% 1.97% 0.42x 1.86x AU$-923.86K
2025 -18.45% -15.65% 0.62x 1.91x AU$-2.67 Million

Industry Comparison

This section compares Resonance Health Ltd's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $19,142,795
  • Average return on equity (ROE) among peers: -52.12%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Resonance Health Ltd (RHT) AU$10.94 Million -18.23% 0.64x $6.64 Million
Adheris Health Limited (AHE) $51.58 Million 1.54% 0.92x $119.94
Alcidion Group Ltd (ALC) $6.57 Million -38.71% 0.23x $60.88 Million
ARTRYA Ltd (AYA) $40.64 Million -42.21% 0.08x $148.36 Million
Blinklab Ltd (BB1) $6.48 Million -27.04% 0.06x $39.10 Million
Beamtree Holdings Ltd (BMT) $29.22 Million 1.31% 0.10x $18.03 Million
Cogstate Ltd (CGS) $29.02 Million 24.18% 1.36x $124.86 Million
Careteq Ltd (CTQ) $3.55 Million -121.85% 1.13x $621.63K
Doctor Care Anywhere Group Plc (DOC) $12.29 Million -179.31% 0.79x $21.76 Million
Echoiq Ltd (EIQ) $6.77 Million -79.92% 0.22x $168.60 Million
Emyria Ltd (EMD) $5.31 Million -59.24% 0.25x $11.75 Million